Neuralink, a brain-chip business founded by Elon Musk, declared on Tuesday that it received permission from an independent evaluation board to begin hiring volunteers for the first human trial of its brain implant intended for paralyzed people.
The experiment will take into account those who have ALS (amyotrophic lateral sclerosis) or cervical spinal cord wounds that have caused paralysis, however, the precise number of individuals who will participate has not been made public. It is anticipated that the trial will last around six years.
The brain-computer interface (BCI) will be surgically implanted in the part of the brain that controls movement intentions as part of a Neuralink study. The initial objective is to empower.
Neuralink had initially planned to get permission to implant its gadget in ten patients.
However, due to concerns regarding safety highlighted by the US Food and Drug Administration (FDA), discussions with the agency resulted in a probable decrease in the overall number of patients. The precise number of patients who received FDA approval is not yet public knowledge.
Elon Musk has bigger plans for Neuralink, hoping to make it easier to put its chip devices during surgery to treat issues including obesity, depression, autism, and schizophrenia. However, experts agree that even if the BCI gadget proves to be safe for human use throughout this study, it may take the business over ten years to obtain commercial usage permission.
Neuralink had previously announced that it had gotten FDA approval for its first human clinical study in May. However, the business was already being investigated by the government for how it handled animal experiments at the time.
Beginning this human study is a critical turning point for Neuralink and a step closer to realizing Elon Musk’s ambition of cutting-edge brain-chip technology.
Also Read: AI Startup Corti Raises $60 Million to Take on Microsoft in Health Care
Based on a report by WIRED, it is now clouded since concerns have been raised regarding claims made by the multi-billionaire surrounding the deaths of monkeys used in Neuralink’s research. According to the article, a medical ethics organization has requested that the Securities and Exchange Commission of the United States (SEC) look into Musk’s assertions that the deaths of the monkeys had nothing to do with the implants made by Neuralink. The organization contends that veterinarian records show that implant-related issues were the real cause of the animals’ deaths.
I am a student pursuing my bachelor’s in information technology. I have a interest in writing so, I am working a freelance content writer because I enjoy writing. I also write poetries. I believe in the quote by anne frank “paper has more patience than person